Position in VTVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,535,663
-$3,702,027 QoQ
Shares Held
139,578
-39.6% QoQ
Ownership
3.54%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trails Edge Capital Partners, LP holds $424,897,513 across 26 Biotechnology names. VTVT ranks #24 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
662,470 | $38,496,131 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
1,738,110 | $32,850,279 | |
| 3 | LBRX |
Lb Pharmaceuticals Inc
|
1,319,362 | $32,535,466 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
333,312 | $30,791,362 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
1,743,220 | $27,019,910 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
440,000 | $25,586,000 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
245,000 | $23,826,250 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
1,047,935 | $22,635,396 |
All Filings in VTVT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,535,663 | 139,578 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,237,690 | 231,000 | Shares | Sole | 2026-02-17 | |
| 2025-08-29 | $5,530,304 | 340,536 | Shares | Sole | 2025-09-08 | |
| No filing history on record for this holder in this stock. | ||||||